articles about vaccine in Press releases

Intervacc AB (publ) is first in the world to show that piglets were protected against the virulent and severe disease-causing S. suis Sequence Types 1 and 16 (serotype 2 and 9, respectively), by vaccinating sows and transferring maternal immunity to piglets. The protection was proven in two separate challenge studies.

Swine Protect & Connect™ advances precision swine health management by integrating intradermal vaccination (PORCILIS^®), needle-free delivery (IDAL™), and animal-level traceability (LeeO) to help maximise swine production.

The Final World Technology Transfer Workshop of the VACDIVA project took place on December 12th, 2024, in Brussels at the European Economic and Social Committee (EESC).

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

Scientists have gained new insights into African swine fever virus (ASFV), a deadly pathogen that causes major losses in global pig farming and threatens global food security.

With this new production facility, Biogénesis Bagó will position itself among the top ten global players in this segment.

More than $2.6 million in new grants are helping Waithaka Mwangi, professor of immunology, develop and validate a vaccine for the deadly African Swine Fever Virus, which threatens U.S. pork producers.

Dr. Waithaka Mwangi, immunology professor in the Department of Diagnostic Medicine/Pathobiology, College of Veterinary at K-State, is developing and validating a vaccine to protect pigs from the virus.

Backed by Horizon Europe and led by HIPRA, the 4-year project bets on the potential of live attenuated vaccines to develop an effective, enduring, and secure solution against ASF virus, contributing to animal welfare, global economic stability, and rural communities.

BIOAFTOGEN^®, the foot-and-mouth disease vaccine produced by Biogénesis Bagó is the first to obtain a prequalification by EuFMD, a commission belonging to the Food and Agriculture Organization of the United Nations (FAO).

Iowa Pork Industry Center has released a new chart that provides a list of diseases, time of administration, and based on risk, available product types.

The new Center on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, will support animal vaccine development and usage.

Animal health company Medgene granted a second Platform technology license to provide solutions for pork producers.

One of the world’s largest animal health companies non-exclusively licensed the USDA and UConn’s jointly owned vaccine candidate for African swine fever.

The Foundation for Food & Agriculture Research recently awarded a grant to the USDA and to Kansas State University to develop vaccines for ASFV.